Introduction {#sec1_1}
============

Celiac disease (CD) is an immune-mediated disease first described by a Greek physician who used the term abdominal diathesis as its clinical manifestation in 100 AD \[[@B1]\]. However, the etiology of this disease remained unknown until 1953, when Dicke et al. \[[@B2]\] noticed that some factor in wheat had a deleterious effect in patients with CD. CD is the most common genetic food intolerance in the world, affecting 1% of the world population, with a predilection towards females \[[@B3]\]. Common gastrointestinal signs and symptoms include chronic diarrhea, chronic constipation, nausea, vomiting, abdominal pain and distention and weight loss \[[@B4]\]. Extraintestinal manifestations might include failure to thrive, stunted growth, delayed puberty, iron deficiency anemia, arthritis, arthralgia, dental enamel defects, elevated liver enzymes, decreased bone mineralization, recurrent mouth ulcers, amenorrhea, dermatitis herpetiformis, irritability, chronic fatigue, depression and anxiety \[[@B4]\]. CD has been linked to a variety of neurological conditions including epilepsy, cerebellar ataxia, chronic neuropathies, myoclonic ataxia, progressive leukoencephalopathy and dementia \[[@B5]\].

Pseudotumor cerebri (PTC) is a disorder characterized by signs and symptoms of increased intracranial pressure such as headache and papilledema, with lack of a structural defect such as an intracranial mass, injury or ventricular dilatation. Neurological examination is usually normal except for papilledema and rarely abducens nerve palsy. We present a case of CD that initially presented as PTC.

Case Report {#sec1_2}
===========

A 14-year-old Caucasian female came to the emergency room with complaints of headache and blurred vision for 1 year that had recently worsened. Headache was in the occipital and frontal region, continuous, pressure-like, non-radiating and not associated with nausea or vomiting. There were no aggravating or relieving factors. She also had blurring of vision in both eyes, but more on the left side, along with pain and redness of the left eye. On review of systems she has no complaint of weakness, numbness, shortness of breath or palpitation. There was no history of trauma. Her past medical history revealed intermittent complaint of constipation for which she was taking a high-fiber diet and laxatives. Her family history showed glaucoma in her paternal grandfather. Her menarche was at the age of 9 years. Physical examination showed blood pressure 120/80 mm Hg, pulse 78/min, temperature 37°C and respiratory rate 18/min. Her head circumference was 57 cm, she was awake and alert, oriented to time place and person. Her weight was 159 pounds (72 kg), her height 5 feet 1 inch and her body mass index 30 kg/m^2^. Respiratory, abdominal, cardiovascular and neurological examinations were normal. Ophthalmological examination showed decreased visual acuity (20/200 on the left side and 20/40 on the right side). Significant bilateral papilledema was found on fundoscopic examination of the eyes, with vessel obscuration and tortuosity of vessels. Magnetic resonance imaging (fig. [1](#F1){ref-type="fig"}) and magnetic resonance venography of the brain showed normal results. Lumber puncture was performed and showed a cerebrospinal fluid opening pressure of 29 cm H~2~O (normal \<20 cm H~2~O); however protein, glucose and cell count of cerebrospinal fluid were within normal limits.

Based on these investigations a diagnosis of PTC was made and the patient was started on a diuretic (acetazolamide 750 mg p.o. twice a day) and advised to lose weight. One month after this visit, the patient was referred to the pediatric gastroenterology clinic for evaluation of abdominal pain due to severe constipation with no bowel movement for 3 days. Pain was described as diffuse, dull and non-radiating, with no aggravating or relieving factors. Physical examination of her abdomen revealed that it was soft and non-tender without visceromegaly. As she had a long history of intermittent constipation with no response to treatment, further workup was performed. This included complete blood counts, erythrocyte sedimentation rate, serum iron, vitamin D levels, urinalysis, serum electrolytes and thyroid studies, and these were reported to be within normal range. Serology for CD showed elevated levels of antiendomysial and tissue transglutaminase IgA antibodies and normal IgA levels. Upper gastrointestinal endoscopy with biopsy was performed. Histopathological examination of the duodenal mucosa showed mild villous blunting and crypt hyperplasia with distended lamina propria and increased plasma cells and increased intraepithelial lymphocytes, confirming the diagnosis of CD (fig. [2](#F2){ref-type="fig"}, fig. [3](#F3){ref-type="fig"}).

The patient was started on a gluten-free diet. On follow-up after 2 months she had complete resolution of constipation. She also reported that she had discontinued acetazolamide due to a remarkable decrease in frequency and severity of headache and blurred vision. Her ophthalmological examination showed visual acuity of 20/20 in both eyes and significantly decreased swelling of the optic disc compared to the previous fundoscopic examination described above, with no vessel obscuration despite the fact that her body mass index was unchanged (30 kg/m^2^). She was continued on a gluten-free diet, and acetazolamide at a decreased dose of 250 mg twice a day (compared to 750 mg b.i.d. at the time of presentation) was re-started by the neuro-ophthalmologist. Her recent follow-up showed complete resolution of headache and blurred vision with no optic disc swelling.

Discussion {#sec1_3}
==========

CD, also known as gluten enteropathy, is an inflammatory autoimmune disease of the small bowel characterized by sensitivity to gluten, a storage protein in wheat, barley and rye. Its etiology is considered to be multifactorial, comprising genetic, immunological and environmental factors. Major histocompatibility complex alleles expressing HLADQ2 and HLADQ8 are present in more than 90--95% of diagnosed CD patients \[[@B6]\]. The disease prevalence is 8--12% in first-degree relatives of affected individuals \[[@B6]\]. Environmental factors include gluten ingestion. Viral infection, pregnancy, high-dose gluten challenge and gastrointestinal surgery may increase the immunological response and can lead to precipitation of CD symptoms \[[@B7]\].

Silent CD is defined as presence of CD-specific antibodies, HLA genotype and small bowel biopsy findings consisting with CD, but absence of gastrointestinal clinical features sufficient for suspicion of CD \[[@B8]\]. Latent CD is defined as presence of associated HLA complex in the absence of enteropathy in patients who have had gluten-dependent enteropathy at some point in their lives \[[@B8]\]. These patients may or may not have CD-specific antibodies or clinical features of CD. Potential CD is defined as presence of associated HLA complexes and antibodies, but no histological features of CD on small intestine biopsy. These patients may or may not have clinical features or gluten-dependent enteropathy later in their lives. Atypical CD presents with the extraintestinal manifestations of CD dominating over the classic symptoms \[[@B8]\].

Neurological manifestation of CD were first described by Cooke and Smith in 16 patients in 1966 \[[@B9]\]. Since then several conditions have been reported in association with CD, such as epilepsy, ataxia, cerebellar ataxia, anxiety, depression, encephalitis, occipital calcification, peripheral neuropathy, neuromuscular disorders, dementia, learning disorders such as attention deficit hyperactivity disorder, developmental delay and migraine \[[@B9]\]. PTC has rarely been described in association with CD. PTC syndrome, also known as idiopathic intracranial hypertension, is characterized by headache, papilledema and normal neurological examination except for cranial nerve palsies and increased intracranial pressure, in the absence of any structural abnormality of the central nervous system. In adults the upper limit of opening increased intracranial pressure is 25 cm H~2~O, while in obese and sedated children this limit is 28 cm H~2~O \[[@B10]\]. The disease has a preponderance towards females with male:female ratio of 1:3 in adults and adolescent, but there is no predilection before puberty. PTC is associated with recent weight gain that is usually acquired 12 months prior to diagnosis. The annual incidence of PTC in the general population is 0.5--1/100,000 \[[@B11]\]. Fewer epidemiological data are available for pediatric PTC, however a German study has shown an incidence of 0.5/100,000 \[[@B11], [@B12]\].

Dotan et al. \[[@B13]\] reported 6 cases of pediatric PTC and described their possible association with nutritional/gastrointestinal factors. All of these 6 cases were found to have low serum vitamin A levels in contrast to the previous hypothesis of hypervitaminosis A causing PTC. Further investigations were done to know the cause of low vitamin A levels, showing self-restriction of diet in 2 patients with autism, malabsorption secondary to CD in 2 patients and unknown etiology in the remaining patients.

In our case, the patient had an initial presentation with classic symptoms of PTC, but later presented to the pediatric gastroenterology clinic for evaluation of constipation and was found to have CD. When she was started on a gluten-free diet, it not only improved gastrointestinal but also neurological symptoms. We thought that her neurological symptoms might have been related to her CD. Even though she was prescribed acetazolamide for PTC and was not compliant with medication, her signs and symptoms improved with introduction of a gluten-free diet. As described previously by Dotan et al. \[[@B13]\], her neurological symptoms could have been caused by malabsorption of a vitamin, such as vitamin A. As her CD improved, her micronutrient deficiency might have been corrected, improving her neurological symptoms. This is contrast to observations made by Ghazal et al. \[[@B14]\], where the patient presented with neurological symptoms and did not have active enteropathy but had potential CD. Authors described a possible immunological cause of neurological symptoms in CD. In any case, the exact mechanism of the relationship between CD and neurological symptoms is not well established at this time and requires further research work.

We present this case to emphasize that CD should be considered in the differential diagnosis of the etiology of PTC. This can lead to early diagnosis and possible treatment of both conditions and prevention of complications of CD and PTC.
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